FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1

F-box and WD repeat domain-containing 7 (FBW7) has been characterized as a tumor suppressor, and its mutation or decreased expression has been observed in many types of human cancers. Our recent studies have uncovered that in pancreatic cancer, the KRAS mutation decreased FBW7 expression through pho...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncol Rep
Главные авторы: Hu, Qiangsheng, Qin, Yi, Zhang, Bo, Liang, Chen, Ji, Shunrong, Shi, Si, Xu, Wenyan, Xiang, Jinfeng, Liang, Dingkong, Ni, Quanxing, Yu, Xianjun, Xu, Jin
Формат: Artigo
Язык:Inglês
Опубликовано: D.A. Spandidos 2017
Предметы:
Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652962/
https://ncbi.nlm.nih.gov/pubmed/28765935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2017.5856
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы